Baliopharm AG

Name: Baliopharm AG
Telephone: +41 61 205 39 10

Swiss Biotech Association

Member

Baliopharm AG, part of the Promethera Biosciences Group, is a biotechnology company focusing on the development of innovative therapeutics for the treatment of chronic liver diseases, immune mediated inflammatory diseases, as well as for cancer.

http://www.baliopharm.com
+41 61 205 39 10
Dr. Andreas Herrmann

Location

Stänzlergasse 4, 4051 Basel,

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2011

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

Cell Receptor SA

Cell Receptor Inc. has IP for improving results in oncological treatment by targeting upstream steps of growth signaling, not noticed in oncology yet. A well-tolerated affordable treatment of low toxicity! It will prevent metastasis in most cancers.
www.nature.com/articles/d43747-021-00133-8
1208 Geneva

Member

LATAM Pharma Innovative Ventures AG

LATAM Pharma offers made-to-measure solutions of immunization to public and private markets in Latin American and Caribbean countries.
6300 Zug

Member

Onward Therapeutics SA

We are a development stage oncology company, focusing on the identification of innovative technologies and the development of truly breakthrough medicines for the treatment of cancer.
1066 Épalinges

Member